Familial hypercholesterolaemia is an inborn defect of cholesterol metabolism, which seems to be considerably more prevalent than previously thought. Given the recently proposed prevalence of 1: 250 in the general population, we estimate up to some 40,000 individuals are affected in the Czech Republic.
FH patients should be diagnosed, adequately informed and treated as early as possible. Comprising of a number of specialised outpatient centres, the MedPed network has been successfully working to this objective for the last 17 years.